Posted in | News | Business | Photovoltaics

Total Purchases 25.4% Share in US-Based AE Polysilicon

Total (Paris:FP)(LSE:TTA)(NYSE:TOT) today announces that its subsidiary Total Gas & Power USA (SAS) has acquired a 25.4% interest in U.S. startup AE Polysilicon Corporation (AEP), which has developed an advanced technology to produce polysilicon for photovoltaic panels. The acquisition is being made through a reserved capital increase.

Founded in 2006 and based in Fairless Hills, Pennsylvania, near Philadelphia, AEP has developed an innovative, low-carbon, energy-efficient process, consuming substantially less energy than standard methods. It operates continuously to produce cost-competitive granular polysilicon.

The initial phase of the state-of-the art polysilicon production facility is in the commissioning phase today and is scheduled to begin commercial production this year. When operating at full capacity, the initial phase will produce up to 1,800 metric tons per year of granular polysilicon.

Total has a technical cooperation agreement encompassing joint development of projects with Total using AEP’s technology, the assignment of Total personnel, and the creation of a joint research center.

Total has also signed a long term agreement to acquire from AEP high purity granular polysilicon, guaranteeing cost-competitive supply for the Group’s solar energy subsidiaries.

“This transaction reflects Total’s commitment to becoming a significant photovoltaic solar operator,” said Philippe Boisseau, President, Total Gas & Power. “We will be able to leverage a new technology to develop capabilities in yet another link in the photovoltaic solar chain, in addition to our current activities.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.